| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 136, 13-16, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
TP Pretlow, MA O'Riordan, MF Kolman and JA Jurcisek
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106.
Aberrant crypts, identified with methylene blue staining of unsectioned colon from carcinogen-treated rats on the basis of their increased size, were examined for the altered expression of hexosaminidase activity. Previously we identified enzyme-altered foci with normal morphology in sections of colon from carcinogen-treated rats. A reduction of histochemically demonstrable hexosaminidase activity was the most consistent marker for these foci. Aberrant crypts, marked with permanent ink and embedded in methacrylate, had a marked decrease of hexosaminidase activity compared to the adjacent, normal crypts. Hexosaminidase may be a marker that will aid in the identification of the molecular basis of colon cancer in a manner similar to that of esterase D and retinoblastoma.
This article has been cited by other articles:
![]() |
T. P. Pretlow, W. Edelmann, R. Kucherlapati, T. G. Pretlow, and L. H. Augenlicht Spontaneous Aberrant Crypt Foci in Apc1638N Mice with a Mutant Apc Allele Am. J. Pathol., November 1, 2003; 163(5): 1757 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Pretlow and T. G. Pretlow Putative Preneoplastic Changes Identified by Enzyme Histochemical and Immunohistochemical Techniques J. Histochem. Cytochem., May 1, 1998; 46(5): 577 - 584. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |